S
Susmita Chatterjee
Researcher at The George Institute for Global Health
Publications - 57
Citations - 2112
Susmita Chatterjee is an academic researcher from The George Institute for Global Health. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 17, co-authored 50 publications receiving 1693 citations. Previous affiliations of Susmita Chatterjee include Saha Institute of Nuclear Physics & Bose Corporation.
Papers
More filters
Journal ArticleDOI
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
Hui Gao,Joshua M. Korn,Stephane Ferretti,John Monahan,Youzhen Wang,Mallika Singh,Mallika Singh,Chao Zhang,Chao Zhang,Christian Schnell,Guizhi Yang,Yun Zhang,O. Alejandro Balbin,Stephanie Barbe,Hongbo Cai,Fergal Casey,Susmita Chatterjee,Derek Y. Chiang,Shannon Chuai,Shawn Cogan,Scott D. Collins,Ernesta Dammassa,Nicolas Ebel,Millicent Embry,John Green,Audrey Kauffmann,Colleen Kowal,Rebecca Leary,Joseph Lehar,Ying Liang,Alice Loo,Edward Lorenzana,E. Robert McDonald,Margaret E. McLaughlin,Jason Merkin,Ronald Meyer,Tara L. Naylor,Montesa Patawaran,Anupama Reddy,Anupama Reddy,Claudia Roelli,David A. Ruddy,Fernando Salangsang,Francesca Santacroce,Angad P Singh,Yan Tang,Walter Tinetto,Sonja Tobler,Roberto Velazquez,Kavitha Venkatesan,Fabian Von Arx,Hui Qin Wang,Zongyao Wang,Marion Wiesmann,Daniel Wyss,Fiona Xu,Hans Bitter,Peter Atadja,Emma Lees,Francesco Hofmann,En Li,Nicholas Keen,Robert Cozens,Michael Rugaard Jensen,Nancy Pryer,Nancy Pryer,Juliet Williams,William R. Sellers +67 more
TL;DR: The results suggest that PCTs may represent a more accurate approach than cell line models for assessing the clinical potential of some therapeutic modalities and could potentially improve preclinical evaluation of treatmentmodalities and enhance the ability to predict clinical trial responses.
Journal ArticleDOI
Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease.
Mark P. Chao,Andrew J. Gentles,Susmita Chatterjee,Feng Lan,Andreas Reinisch,M. Ryan Corces,Seethu Xavy,Jinfeng Shen,Daniel Haag,Soham Chanda,Rahul Sinha,Rachel M. Morganti,Toshinobu Nishimura,Mohamed Ameen,Haodi Wu,Marius Wernig,Joseph C. Wu,Joseph C. Wu,Ravindra Majeti +18 more
TL;DR: Induced pluripotent stem cells from AML patient samples harboring MLL rearrangements were generated and found that they retained leukemic mutations but reset leukedmic DNA methylation/gene expression patterns, including an aberrant MLL signature.
Journal ArticleDOI
Unit cost of medical services at different hospitals in India.
Susmita Chatterjee,Carol Levin,Ramanan Laxminarayan,Ramanan Laxminarayan,Ramanan Laxminarayan +4 more
TL;DR: The study demonstrates that detailed costing of Indian hospital operations is both feasible and essential, given the significant variation in the country’s hospital types, and can help hospital administrators understand their cost structures and run their facilities more efficiently.
Journal ArticleDOI
Cost of diabetes and its complications in Thailand: a complete picture of economic burden
Susmita Chatterjee,Arthorn Riewpaiboon,Piyanuch Piyauthakit,Wachara Riewpaiboon,Kuanoon Boupaijit,Niphaphat Panpuwong,Vorachai Archavanuntagul +6 more
TL;DR: The present study estimated the cost of illness of diabetes from societal perspective, the broadest viewpoint covering all costs irrespective of who incur them, to capture the complete picture of economic burden caused by diabetes.
Journal ArticleDOI
Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models.
Nicolas A Menzies,Gabriela B. Gomez,Gabriela B. Gomez,Fiammetta Bozzani,Susmita Chatterjee,Nicola L. Foster,Ines Garcia Baena,Yoko V. Laurence,Sun Qiang,Andrew M. Siroka,Sedona Sweeney,Stéphane Verguet,Nimalan Arinaminpathy,Nimalan Arinaminpathy,Andrew S. Azman,Eran Bendavid,Stewart T. Chang,Ted Cohen,Justin T Denholm,David W. Dowdy,Philip A. Eckhoff,Jeremy D. Goldhaber-Fiebert,Andreas Handel,Grace H. Huynh,Marek Lalli,Hsien-Ho Lin,Sandip Mandal,Emma S. McBryde,Emma S. McBryde,Surabhi Pandey,Joshua A. Salomon,Sze-chuan Suen,Tom Sumner,James M. Trauer,James M. Trauer,Bradley G. Wagner,Christopher C. Whalen,Chieh Yin Wu,Delia Boccia,Vineet K. Chadha,Salome Charalambous,Daniel P. Chin,Gavin J. Churchyard,Gavin J. Churchyard,Colleen Daniels,Puneet Dewan,Lucica Ditiu,Jeffrey W. Eaton,Alison D. Grant,Alison D. Grant,Alison D. Grant,Piotr Hippner,Mehran Hosseini,David Mametja,Carel Pretorius,Yogan Pillay,Kiran Rade,Suvanand Sahu,Lixia Wang,Rein M G J Houben,Michael E. Kimerling,Richard G. White,Anna Vassall +62 more
TL;DR: In general, expansion of tuberculosis services substantially reduced patient-incurred costs and, in India and China, produced net cost savings for most interventions under a societal perspective, and most intervention approaches seemed highly cost-effective.